Status:
COMPLETED
Study for Evaluating Different Methods of Measuring Depression Treatment Response
Lead Sponsor:
Pfizer
Conditions:
Depressive Disorder, Major
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Purpose of the study is to evaluate use of electronic diaries and voice acoustics for use in future depression clinical trial. Focus is on increased precision of measurement.
Eligibility Criteria
Inclusion
- Primary diagnosis of Major Depressive Disorder with symptoms of depression present at least 1 month
- Psychotropic medications currently not being taken
Exclusion
- Failure to respond in past 5 years to antidepressant therapy of adequate duration and dosing
- Diagnoses of following conditions or disorders within past 6 months: generalized anxiety, obsessive compulsive, panic, post stress, anorexia, bulimia, alcohol or substance abuse or social anxiety disorder
- Diagnoses current or past of the following conditions or disorders: schizophrenia, psychotic disorder, delieium, dememtia, amnestic cognitive disorder, bipolar
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT00406952
Start Date
November 1 2006
End Date
August 1 2007
Last Update
August 21 2008
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Norwich, Connecticut, United States, 06360
2
Pfizer Investigational Site
Aventura, Florida, United States, 33180
3
Pfizer Investigational Site
Jacksonville, Florida, United States, 32216
4
Pfizer Investigational Site
Miami, Florida, United States, 33125